Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 136

1.
2.

Discussion sections in reports of controlled trials published in general medical journals.

Clarke M, Alderson P, Chalmers I.

JAMA. 2002 Jun 5;287(21):2799-801.

PMID:
12038916
4.

Consolidated standards of reporting trials (CONSORT) and the completeness of reporting of randomised controlled trials (RCTs) published in medical journals.

Turner L, Shamseer L, Altman DG, Weeks L, Peters J, Kober T, Dias S, Schulz KF, Plint AC, Moher D.

Cochrane Database Syst Rev. 2012 Nov 14;11:MR000030. doi: 10.1002/14651858.MR000030.pub2. Review.

PMID:
23152285
5.

Comparison of reports of randomized controlled trials and systematic reviews in surgical journals: literature review.

Panesar SS, Thakrar R, Athanasiou T, Sheikh A.

J R Soc Med. 2006 Sep;99(9):470-2. Review.

6.

An analysis of systematic reviews indicated low incorpororation of results from clinical trial quality assessment.

de Craen AJ, van Vliet HA, Helmerhorst FM.

J Clin Epidemiol. 2005 Mar;58(3):311-3.

PMID:
15718121
7.

The scatter of research: cross sectional comparison of randomised trials and systematic reviews across specialties.

Hoffmann T, Erueti C, Thorning S, Glasziou P.

BMJ. 2012 May 17;344:e3223. doi: 10.1136/bmj.e3223.

8.

Procedures and methods of benefit assessments for medicines in Germany.

Bekkering GE, Kleijnen J.

Eur J Health Econ. 2008 Nov;9 Suppl 1:5-29. doi: 10.1007/s10198-008-0122-5.

PMID:
18987905
9.

Interventions to improve the use of systematic reviews in decision-making by health system managers, policy makers and clinicians.

Murthy L, Shepperd S, Clarke MJ, Garner SE, Lavis JN, Perrier L, Roberts NW, Straus SE.

Cochrane Database Syst Rev. 2012 Sep 12;(9):CD009401. doi: 10.1002/14651858.CD009401.pub2. Review.

PMID:
22972142
10.

Quality of reporting of randomized controlled trials of pharmacologic treatment of bipolar disorders: a systematic review.

Strech D, Soltmann B, Weikert B, Bauer M, Pfennig A.

J Clin Psychiatry. 2011 Sep;72(9):1214-21. doi: 10.4088/JCP.10r06166yel. Review.

PMID:
21294992
11.

Global collaborative networks on meta-analyses of randomized trials published in high impact factor medical journals: a social network analysis.

Catalá-López F, Alonso-Arroyo A, Hutton B, Aleixandre-Benavent R, Moher D.

BMC Med. 2014 Jan 29;12:15. doi: 10.1186/1741-7015-12-15. Review.

12.

[Procedures and methods of benefit assessments for medicines in Germany].

Bekkering GE, Kleijnen J.

Dtsch Med Wochenschr. 2008 Dec;133 Suppl 7:S225-46. doi: 10.1055/s-0028-1100954. German.

PMID:
19034813
13.

Medical journals' conflicts of interest in the publication of book reviews.

Davis RM, Neale AV, Monsur JC.

Sci Eng Ethics. 2003 Oct;9(4):471-83.

PMID:
14652900
14.

Transparency of outcome reporting and trial registration of randomized controlled trials in top psychosomatic and behavioral health journals: A systematic review.

Milette K, Roseman M, Thombs BD.

J Psychosom Res. 2011 Mar;70(3):205-17. doi: 10.1016/j.jpsychores.2010.09.015. Review.

PMID:
21334491
15.
16.

Reporting adverse events in randomized controlled trials.

Nuovo J, Sather C.

Pharmacoepidemiol Drug Saf. 2007 Mar;16(3):349-51.

PMID:
16998947
18.
19.

Value of flow diagrams in reports of randomized controlled trials.

Egger M, Jüni P, Bartlett C; CONSORT Group (Consolidated Standards of Reporting of Trials)..

JAMA. 2001 Apr 18;285(15):1996-9.

PMID:
11308437
20.

Reporting on methods of subgroup analysis in clinical trials: a survey of four scientific journals.

Moreira ED Jr, Stein Z, Susser E.

Braz J Med Biol Res. 2001 Nov;34(11):1441-6.

Supplemental Content

Support Center